IMCC press release
RTPR•04/11/2026•16:01 ET
0
Key Highlights
- ➤US$1.2 million convertible note financing closed with existing institutional investor
- ➤Convertible note carries 4% annual interest and matures 28 months after issuance
- ➤Conversion price is lower of US$0.610 or 85% of recent VWAP, with US$0.1449 floor
- ➤Investor received warrants for 3,936,330 shares exercisable at US$0.610 through November 3, 2029
- ➤Company may request up to US$1.2 million in additional quarterly notes beginning January 1, 2027
IM Cannabis Raises US$1,200,000 of Gross Proceeds in Convertible Note Financing PR Newswire
VANCOUVER and GLIL YAM, Israel, Nov. 4, 2026 /PRNewswire/ -- IM Cannabis Corp. ("IMCC" or the "Company") (Nasdaq: IMCC), a medical cannabis company with operations in Israel, today announced the closing of a US$1,200,000 convertible note financing in a private placement with an existing institutional investor (the "Investor").
Get started
Create a free account to read the full story.